Ophthalmology Times3d
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...
NYU Grossman School of Medicine5d
Division of Biostatistics Clinical Trials Pillar
The Clinical Trials Research Pillar in the Division of Biostatistics is at the forefront of innovative clinical trial design ...
CURE6d
The Role of Circulating Tumor DNA in Breast Cancer Monitoring
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.